上海CMC培訓 Drug Master Files

上海CMC培訓 Drug Master Files

ID:37128067

大?。?35.00 KB

頁數(shù):49頁

時間:2019-05-10

上海CMC培訓 Drug Master Files_第1頁
上海CMC培訓 Drug Master Files_第2頁
上海CMC培訓 Drug Master Files_第3頁
上海CMC培訓 Drug Master Files_第4頁
上海CMC培訓 Drug Master Files_第5頁
資源描述:

《上海CMC培訓 Drug Master Files》由會員上傳分享,免費在線閱讀,更多相關(guān)內(nèi)容在教育資源-天天文庫。

1、DrugMasterFilesCharlesTong,Ph.D.GlobalCMC,PfizerInc.AAPS/CPAWorkshop28-29June2010,Shanghai,China0OutlineDrugMasterFilesintheUSComparisonofUSDMF,EuropeanASMFandCEPRDPACProposalforDMFinChina1DrugMasterFilesintheUSWhataDMFisandisnotTypesofDMFsElectronicfilingandCTD-QAdministrative

2、informationTechnicalinformationbytypeofDMFReviewprocessTechnicalamendmentprocessInteractionbetweenFDAandDMFholderduringDMFreviewIssuesofconcernsfordrugmanufacturersRemarks2WhataDrugMasterFileisandisnotADrugMasterFile(DMF)isasubmissiontoFDAthatmaybeusedtoprovideconfidentialdetai

3、ledinformationaboutfacilities,processes,orarticlesusedinthemanufacturing,processing,packaging,andstoringofoneormorehumandrugsThesubmissionofaDMFisnotrequiredbylaworregulation.ADMFissubmittedsolelyatthediscretionoftheholder.ADMFusuallycoversmanufacturinginformationnotconsideredr

4、eleasableviaaFreedomofInformationAct(FOIA)requestThereareno“Open”and“Closed”partsofaDMF3WhataDrugMasterFileisandisnot(cont’d)TheinformationcontainedintheDMFmaybeusedtosupportanInvestigationalNewDrugApplication(IND),aNewDrugApplication(NDA),AbbreviatedNewDrugApplication(ANDA),an

5、otherDMF,ExportApplication,oramendmentsandsupplementstoanyoftheseADMFisnotasubstituteforanIND,NDA,ANDA,orExportApplicationTechnicalcontentsofaDMFarereviewedonlyinconnectionwiththereviewofanIND,NDA,ANDA,oranExportApplicationDMFisnotapprovedordisapprovedFDAwilldetermineifitstechn

6、icalcontentisacceptableordeficientinsupportoftherelatedapplicationIfdeficient,aletterissent.Ifacceptable,noletterissent.4TypesofDMFs*TypeII:Drugsubstance,drugproduct,intermediates,andmaterialusedintheirmanufactureTypeIII:PackagingmaterialTypeIV:Excipients,colorant,flavor,essenc

7、e,ormaterialusedintheirpreparationTypeV:OtherreferenceinformationacceptedbyFDAe.g.,sterilemanufacturingfacilities,biotechcontractfacilities,clinical,toxicology*TypeIformanufacturingfacilitywaseliminatedinJanuary2000.5ActivevsInactiveDMFsasofJanuary11,2010(Total23,453)9,789Activ

8、e42%Inactive58%13,664NumberofDMFsAsofJanuary11,2010,th

當前文檔最多預覽五頁,下載文檔查看全文

此文檔下載收益歸作者所有

當前文檔最多預覽五頁,下載文檔查看全文
溫馨提示:
1. 部分包含數(shù)學公式或PPT動畫的文件,查看預覽時可能會顯示錯亂或異常,文件下載后無此問題,請放心下載。
2. 本文檔由用戶上傳,版權(quán)歸屬用戶,天天文庫負責整理代發(fā)布。如果您對本文檔版權(quán)有爭議請及時聯(lián)系客服。
3. 下載前請仔細閱讀文檔內(nèi)容,確認文檔內(nèi)容符合您的需求后進行下載,若出現(xiàn)內(nèi)容與標題不符可向本站投訴處理。
4. 下載文檔時可能由于網(wǎng)絡(luò)波動等原因無法下載或下載錯誤,付費完成后未能成功下載的用戶請聯(lián)系客服處理。